SPS 2018: Implementing Human iPSC-derived Cells in Early Safety Assessment & Disease Modeling

SPS 2018: Implementing Human iPSC-derived Cells in Early Safety Assessment & Disease ModelingПодробнее

SPS 2018: Implementing Human iPSC-derived Cells in Early Safety Assessment & Disease Modeling

Using Human iPSC-derived Cell-Types in Novel Functional Assays, Disease Modeling and Drug DiscoveryПодробнее

Using Human iPSC-derived Cell-Types in Novel Functional Assays, Disease Modeling and Drug Discovery

Human iPSC-based disease modeling and therapeutic developmentПодробнее

Human iPSC-based disease modeling and therapeutic development

Human iPSC-derived Midbrain Dopaminergic Neurons for Parkinson’s Disease Modeling and Cell TherapyПодробнее

Human iPSC-derived Midbrain Dopaminergic Neurons for Parkinson’s Disease Modeling and Cell Therapy

Probing disease mechanisms in ALS using iPSCs, reprogramming and optogenetic approachesПодробнее

Probing disease mechanisms in ALS using iPSCs, reprogramming and optogenetic approaches

Advances in Modeling Human Diseases Using Induced Pluripotent Stem Cell-derived Cellular ModelsПодробнее

Advances in Modeling Human Diseases Using Induced Pluripotent Stem Cell-derived Cellular Models

Utilizing Stem Cell-derived Cardiomyocytes for Early Safety Screening - Webinar PresentationПодробнее

Utilizing Stem Cell-derived Cardiomyocytes for Early Safety Screening - Webinar Presentation

Tools & Strategies for Implementing iPSC-based Cell Models for Neurodegenerative Disease Drug Dis...Подробнее

Tools & Strategies for Implementing iPSC-based Cell Models for Neurodegenerative Disease Drug Dis...

Using Patient Specific iPSC-Cardiomyocytes for Disease ModelingПодробнее

Using Patient Specific iPSC-Cardiomyocytes for Disease Modeling

Using iPS cell technology to model human neurodegenerative diseasesПодробнее

Using iPS cell technology to model human neurodegenerative diseases

Improvements in building in vitro pluripotent stem cell-derived disease modelsПодробнее

Improvements in building in vitro pluripotent stem cell-derived disease models

IPSC-Derived Human Neurons: Introduction and ApplicationПодробнее

IPSC-Derived Human Neurons: Introduction and Application

Webinar: APC & iPSC: iPSC-derived human neurons and glia for disease modeling and drug discoveryПодробнее

Webinar: APC & iPSC: iPSC-derived human neurons and glia for disease modeling and drug discovery

Cardiac proarrhythmic risk assessment using human iPSC-derived cardiomyocytes - Session 1Подробнее

Cardiac proarrhythmic risk assessment using human iPSC-derived cardiomyocytes - Session 1

Refining Toxicity Testing through Advances in Human iPSC TechnologyПодробнее

Refining Toxicity Testing through Advances in Human iPSC Technology

Modeling Barth syndrome using patient-specific, iPSC-derived cardiomyocytesПодробнее

Modeling Barth syndrome using patient-specific, iPSC-derived cardiomyocytes

Exploring the Role of iPSC-cardiomyocytes in Drug Discovery and Safety AssessmentПодробнее

Exploring the Role of iPSC-cardiomyocytes in Drug Discovery and Safety Assessment

Next-Generation Sequencing to Understand the Function of miRNAs in Human IPSC-Cardiomyocyte..Подробнее

Next-Generation Sequencing to Understand the Function of miRNAs in Human IPSC-Cardiomyocyte..

Functional Assessment of Cardiomyocytes Derived from Human Pluripotent Stem CellsПодробнее

Functional Assessment of Cardiomyocytes Derived from Human Pluripotent Stem Cells

Популярное